Last updated: April 22, 2020

On this page you'll find answers to commonly asked questions pertaining to Cornell IBC office functions and review of research with recombinant or synthetic nucleic acid molecules or other infectious agents during the COVID-19 Pandemic.

IBC Office Hours and Information during the COVID-19 Pandemic

A: Yes. The IBC Committee and staff are functioning remotely during regular business hours.

A: The easiest way to contact the IBC is by emailing cu_ibc@cornell.edu. You can also find contact information for specific IBC staff on our website. IBC staff are responding to both email and phone messages during regular business hours, with email being the fastest way to get in touch. Staff are also happy to arrange phone calls or Zoom meetings, as needed.

Submitting to the IBC

A: Yes, the IBC is still reviewing and approving IBC submissions. Please note these approvals do NOT supersede the guidance posted on the Research Continuity Webpage.

A: Maybe. As part of Cornell’s reduction of laboratory research (see Brief Contingency Planning guidance for Researchers March 15, 2020), research on campus should be halted with the following exceptions:

A: Yes if the work approved by the committees / individuals above involves use of recombinant or synthetic nucleic acid molecules or other infectious agents and is not already covered under your Memorandum of Understanding and Agreement (MUA) with the IBC you will need to amend your MUA. 

The IBC is working to expedite this work considered essential under COVID-19.

A:  Access your current MUA.  If you need assistance, please contact the IBC Office.

Submitting New and Continuing Renewals to the IBC

A: To create a new MUA , Click the Create MUA button and the electronic form will be open to you. For guidance, please contact the IBC Office.

A: Yes.  Even if the research is paused for the time being, the PI must still submit the Annual Review or 3-year renewal to ensure that the study stays active.  This will allow the research to begin immediately when appropriate and/or permitted.